Verrica Pharmaceuticals VRCA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Stage Continues Alerus Financial Q1 2026 Earnings Significant EPS Beat Fails to Lift Stock as Market Reacts to Uncertain Outlook GXO Q1 2026 Earnings Earnings Beat Expectations with 34 Surprise Stock Gains MX Q1 2026 Earnings EPS Beat by 5146 but Stock Declines 67 MXC Q3 2025 Earnings Profitability Remains Solid Amid Quiet Quarter DDS Q1 2026 Earnings Earnings Miss Estimates Despite Positive Stock Reaction